Progress in FDA pharmacosurveillance.
作者信息
Keller W C
出版信息
J Am Vet Med Assoc. 1996 Nov 1;209(9):1546-7.
PMID:8899014
Abstract
摘要
相似文献
1
Progress in FDA pharmacosurveillance.美国食品药品监督管理局药物监测进展
J Am Vet Med Assoc. 1996 Nov 1;209(9):1546-7.
2
Processing and evaluation of adverse drug experience reports at the Food and Drug Administration Center for Veterinary Medicine.美国食品药品监督管理局兽药中心对药品不良反应报告的处理与评估
J Am Vet Med Assoc. 1998 Jul 15;213(2):208-11.
3
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance.
Int J Pharm Compd. 2015 Nov-Dec;19(6):449-50.
4
Summary of adverse event reports for veterinary biologic products received by the USDA from 1999 through 2005.
J Am Vet Med Assoc. 2006 Oct 1;229(7):1100-2. doi: 10.2460/javma.229.7.1100.
5
Fort Dodge recalls ProHeart 6, citing FDA safety concerns. Advisory committee to review FDA findings.辉瑞动物保健公司召回“保心宁6号”，称美国食品药品监督管理局（FDA）存在安全担忧。咨询委员会将审查FDA的调查结果。
J Am Vet Med Assoc. 2004 Oct 15;225(8):1157-8.
6
Veterinary medicines--suspected adverse reactions, 1997.
Vet Rec. 1998 Jul 18;143(3):60-1.
7
Suspected adverse drug reactions in the Hungarian veterinary practice between 1982 and 1992.
Acta Vet Hung. 1996;44(4):451-6.
8
FDA bans firms from importing and distributing contaminated animal drugs.美国食品药品监督管理局禁止企业进口和分销受污染的兽药。
J Am Vet Med Assoc. 1999 May 15;214(10):1459.
9
MedWatch, the new FDA adverse effects reporting system.MedWatch，美国食品药品监督管理局新的不良反应报告系统。
J Clin Psychopharmacol. 1993 Oct;13(5):303-4.
10
Review of suspected adverse reactions surveillance scheme.疑似不良反应监测方案综述
Vet Rec. 2002 Feb 16;150(7):223.
Zotero 插件